Vicore Pharma Holding AB Sustainability Reports
Vicore Pharma Holding AB is a clinical-stage pharmaceutical company that develops therapies for respiratory diseases. Its main focus is on the development of small-molecule drug candidates targeting fibrotic lung conditions like idiopathic pulmonary fibrosis.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300KTNBPTZLF01130
FIGI: BBG0039D29X7
5 reports from 2019 to 2025